List view / Grid view
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
14 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The surprise is that diabetic mice absorb more fructose within minutes after it hits the stomach, sending it to the liver where it manufactures fat...
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
It is difficult to estimate the global burden of cardiovascular disease in people with diabetes, due to lack of data and standardisation...
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A new research funding agreement aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with...
15 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Drug Target Review caught up with Dr Emily Burns, Research Communications Manager Diabetes UK to find out how this smartphone craze could impact the rising levels of Diabetes…
6 July 2016 | By Victoria White, Digital Content Producer
The widely-used diabetes drug, metformin, reduced the toxic acid levels associated with MSUD in both skin cells derived from MSUD patients and in mice...
The study of biochemistry provides molecular insights into how the human population ages, how diseases commence and progress, how molecular changes relate to disease remission and relapse, and how humans respond to treatments...
14 June 2016 | By Victoria White, Digital Content Producer
The discovery demonstrates that Darapladib has potential to provide protection against vision loss in a much wider group of patients with diabetes...
7 June 2016 | By Victoria White, Digital Content Producer
A drug that affects the activity of the TST gene has been shown to reduce the symptoms of type 2 diabetes in obese mice and could lead to new treatments...
3 June 2016 | By Victoria White, Digital Content Producer
Researchers are to examine DNA samples from 20,000 people with diabetes to help identify the genetic factors in diabetic kidney disease...
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have described a potential new intraocular treatment that prevents and reverses some characteristics of diabetic retinopathy in a mouse model...
28 April 2016 | By Victoria White, Digital Content Producer
A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
